Evgen Pharma tests with charitable donation
Evgen Pharma said Tuesday that its lead product, SFX-01, will be tested against triple negative breast cancer (TNBC) in new preclinical research at the Manchester Cancer Research Centre, UK...
Subscribe to Read More...
Your comment will be posted after it is approved.
Leave a Reply.
Create a free website